Gut microbiome interventions in human health and diseases. Issue 6 (17th April 2019)

• Record Type: Journal Article
• Authors: Nie, Pengqing; Li, Zhiqiang; Wang, Yimeng; Zhang, Yubing; Zhao, Mengna; Luo, Jie; Du, Shiming; Deng, Zixin; Chen, Jincao; Wang, Yunfu; Chen, Shi; Wang, Lianrong
• Is Part Of: Medicinal research reviews. Volume 39:Issue 6(2019)
• Page Start: 2286
• Page End: 2313
• Publication Date: 2019-04-17
• Subjects: brain disorders -- cancer -- gut microbiota -- gut microbiota modulation -- immune response -- metabolic disorders -- systemic inflammation; Pharmacology -- Periodicals; Drugs -- Research -- Periodicals; 615
• DOI: 10.1002/med.21584
• Languages: English
• ISSNs: 0198-6325

Abstract

Abstract: Ongoing studies have determined that the gut microbiota is a major factor influencing both health and disease. Host genetic factors and environmental factors contribute to differences in gut microbiota composition and function. Intestinal dysbiosis is a cause or a contributory cause for diseases in multiple body systems, ranging from the digestive system to the immune, cardiovascular, respiratory, and even nervous system. Investigation of pathogenesis has identified specific species or strains, bacterial genes, and metabolites that play roles in certain diseases and represent potential drug targets. As research progresses, gut microbiome–based diagnosis and therapy are proposed and applied, which might lead to considerable progress in precision medicine. We further discuss the limitations of current studies and potential solutions.